In patients with EGFR-mutant NSCLC and brain metastases, craniocerebral radiotherapy followed by EGFR-TKIs improved iPFS compared with upfront EGFR-TKI, showing that the delay or lack of craniocerebral radiotherapy was associated with a poor PFS (8). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.